Evidence map›Paper›PMID 26951121›Full record

ArticleInternational journal of clinical pharmacy2016

Lack of pharmacist-physician communication associated with nimesulide-induced oligohydramnios during pregnancy.

Švitrigailė Grincevičienė, Jelena Volochovič, Jonas Grincevičius

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Švitrigailė GrincevičienėDepartment of Biothermodynamics and Drug Design, Institute of Biotechnology, Vilnius University, V. Graičiūno 8, 02241, Vilnius, Lithuania. svitrigaile@gmail.com.
Jelena VolochovičCentre of Obstetrics and Gynaecology, Hospital "Santariškių Klinikos", Vilnius University, Santariškių st. 2, 08661, Vilnius, Lithuania.
Jonas GrincevičiusDepartment of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Lithuanian University of Health Sciences, Sukilėlių ave. 13, 50161, Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTVilnius University · LTVilnius University Hospital Santariskiu Klinikos · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

caseThe consequences of medication errors can be serious, especially in pregnant women. When decision-making is critical, physician-pharmacist communication has the potential to improve patient safety. In this report, we describe the case of a pregnant woman who developed oligohydramnios after taking nimesulide for neuropathic pain. The drug was improperly prescribed by a family physician and mistakenly dispensed by a community pharmacist. Oligohydramnios was observed during ultrasound examination and an iatrogenic cause was suspected. This case is presented to raise awareness that patient safety is threatened because of a lack of physician-pharmacist communication, especially for pregnant patients.

conclusionHealthcare professionals are continually at-risk for making errors at work. Effective inter-professional communication should be an organisational tool to prevent adverse events for pregnant women.

Indexed as

CommunicationAdultAnti-Inflammatory Agents, Non-SteroidalFemaleHumansInterprofessional RelationsMedication ErrorsOligohydramniosPharmacistsPhysiciansPregnancySulfonamidesAnti-Inflammatory Agents, Non-SteroidalnimesulideSulfonamidesMedication errorNimesulideOligohydramniosPhysician–pharmacist communicationPregnancy

Identifiers

PMID26951121
OpenAlexW2295351902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.